We are live on ! Find out more
NAP

New Amsterdam Partners Portfolio holdings

AUM $272M
1-Year Est. Return 12.21%
This Fund
S&P 500
This Quarter Est. Return
+9.68%
1 Year Est. Return
+12.21%
3 Year Est. Return
+73.94%
5 Year Est. Return
+120.95%
10 Year Est. Return
AUM
$1.24B
AUM Growth
+$89.5M
Cap. Flow
-$300K
Cap. Flow %
-0.02%
Top 10 Hldgs %
24.09%
Holding
142
New
28
Increased
56
Reduced
32
Closed
24

Top Buys

Rank Stock Value
1
UFS
DOMTAR CORPORATION (New)
UFS
+$22.1M
2
JBLU icon
JetBlue
JBLU
+$21.8M
3
TTC icon
Toro Company
TTC
+$21.6M
4
DLX icon
Deluxe
DLX
+$16.8M
5
FDS icon
Factset
FDS
+$14.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.51%
2 Technology 16.85%
3 Industrials 14.23%
4 Financials 13.69%
5 Healthcare 13.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAI
51
DELISTED
CAI International, Inc.
CAI
$5.26M 0.42%
214,031
+50,648
+31% +$1.17M
CACC icon
52
Credit Acceptance
CACC
$6.18B
$5.15M 0.42%
26,419
-5,208
-16% -$881K
HCI icon
53
HCI Group
HCI
$2.32B
$5.09M 0.41%
110,952
+153
+0.1% +$7.09K
EGBN icon
54
Eagle Bancorp
EGBN
$840M
$4.98M 0.4%
129,627
+168
+0.1% +$5.99K
SCL icon
55
Stepan Co
SCL
$1.42B
$4.97M 0.4%
+119,395
New +$4.75M
LKFN icon
56
Lakeland Financial Corp
LKFN
$1.48B
$4.94M 0.4%
182,735
+243
+0.1% +$6.5K
AAPL icon
57
Apple
AAPL
$4.67T
$4.94M 0.4%
158,688
+360
+0.2% +$10.9K
NUS icon
58
Nu Skin
NUS
$236M
$4.93M 0.4%
81,827
+2,643
+3% +$135K
SR icon
59
Spire
SR
$4.88B
$4.89M 0.39%
95,418
+48,679
+104% +$2.55M
IOSP icon
60
Innospec
IOSP
$2.35B
$4.88M 0.39%
+105,243
New +$4.52M
BRLI
61
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
$4.84M 0.39%
+137,335
New +$4.65M
CTSH icon
62
Cognizant
CTSH
$28.8B
$4.61M 0.37%
73,815
+29
+0% +$1.71K
MANH icon
63
Manhattan Associates
MANH
$13B
$4.51M 0.36%
89,181
+86
+0.1% +$4.15K
OME
64
DELISTED
Omega Protein
OME
$4.49M 0.36%
327,994
+1,294
+0.4% +$14.9K
LOPE icon
65
Grand Canyon Education
LOPE
$3.94B
$4.48M 0.36%
103,519
+65,967
+176% +$2.96M
WU icon
66
Western Union
WU
$2.26B
$4.25M 0.34%
204,053
+98,206
+93% +$1.83M
CI icon
67
Cigna
CI
$73.7B
$4.24M 0.34%
32,735
-6,285
-16% -$730K
BIIB icon
68
Biogen
BIIB
$32.3B
$4.21M 0.34%
9,959
+18
+0.2% +$7.09K
ALK icon
69
Alaska Air
ALK
$4.72B
$4.15M 0.34%
62,721
-461,989
-88% -$30M
FFG
70
DELISTED
FBL Financial Group
FFG
$4.12M 0.33%
66,411
-11,825
-15% -$671K
DGX icon
71
Quest Diagnostics
DGX
$26.8B
$3.98M 0.32%
51,827
+3,939
+8% +$282K
PRLB icon
72
Protolabs
PRLB
$1.91B
$3.92M 0.32%
56,003
+371
+0.7% +$25.1K
EBS icon
73
Emergent Biosolutions
EBS
$303M
$3.92M 0.32%
136,116
-37,787
-22% -$1.08M
META icon
74
Meta Platforms (Facebook)
META
$1.47T
$3.88M 0.31%
47,209
+17
+0% +$1.33K
TSCO icon
75
Tractor Supply
TSCO
$18.1B
$3.88M 0.31%
228,140
-45,205
-17% -$755K

Similar funds

New Amsterdam Partners's Q1 2015 Portfolio in Review

As of Q1 2015, New Amsterdam Partners held 142 positions worth $1.24B, up 7.8% from $1.15B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New Amsterdam Partners's Q1 2015 filing shows 28 new, 56 increased, 32 reduced and 24 closed positions. Its largest new stake was DOMTAR CORPORATION (New): 524,114 shares worth $24.2M. The largest sale was Alaska Air, an estimated $30M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

  • New Amsterdam Partners's largest Q1 2015 buy was DOMTAR CORPORATION (New): 524,114 shares worth $24.2M.
  • New Amsterdam Partners added most to ITC HOLDINGS CORP in Q1 2015, an estimated $10.3M increase.
  • New Amsterdam Partners's biggest Q1 2015 reduction was Alaska Air, cutting an estimated $30M.
  • New Amsterdam Partners fully exited SOLARWINDS INC COM STK (DE) in Q1 2015, selling an estimated $18.3M.
  • New Amsterdam Partners's ten largest holdings make up 24% of its $1.24B portfolio in Q1 2015.
  • New Amsterdam Partners opened 28 new positions and closed 24 in Q1 2015.
  • New Amsterdam Partners's portfolio value rose 7.8% quarter-over-quarter to $1.24B.

Based on New Amsterdam Partners's 13F filing for Q1 2015, filed 11 May 2015.